Guangdong Taienkang Pharmaceutical Co., Ltd. (SHE:301263)

China · Delayed Price · Currency is CNY

18.01

-0.18 (-0.99%)

Oct 27, 2026, 4:00 PM EDT

Market Cap	9.15B -29.3%
Revenue (ttm)	681.75M +1.1%
Net Income	28.71M +23.3%
EPS	0.06 +36.7%
Shares Out	508.21M
PE Ratio	296.39
Forward PE	n/a
Dividend	0.04 (0.23%)
Ex-Dividend Date	Jun 1, 2026

Volume	5,114,160
Open	18.68
Previous Close	18.19
Day's Range	18.01 - 19.18
52-Week Range	16.88 - 29.78
Beta	0.29
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 27, 2026

About SHE:301263

Guangdong Taienkang Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in China and internationally. The company offers various products covering various therapeutic areas, including sexual health medicines, ophthalmic medicines, gastrointestinal medicines, Chinese patent medicines and external medicines, and sanitary materials in the form of tablets, pills, injections, and essential oils; medical technology and technology transfer services; and medical devices. It also operates as ... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1999

Employees 1,154

Stock Exchange Shenzhen Stock Exchange

Ticker Symbol 301263

Full Company Profile

Financial Performance

In 2025, SHE:301263's revenue was 674.90 million, a decrease of -6.40% compared to the previous year's 721.03 million. Earnings were 28.63 million, a decrease of -73.54%.

Financial Statements